Current Neuro-Oncology
Volume
22 Number 22
30 November 2020
Home > Publications > Current Neuro-Oncology > Volume 22, Year 2020 > Number 22, 30 November
Curtin
L, Whitmire P, Rickertsen CR, Mazza GL, Canoll P, Johnston SK,
Mrugala MM, Swanson KR, Hu LS.
Assessment
of Prognostic Value of Cystic Features in Glioblastoma Relative to
Sex and Treatment With Standard-of-Care.
Front
Oncol. 2020 Nov 16, 2020;10:580750∟.
doi: 10.3389/fonc.2020.580750∟.
PMID: 33282737∟.
Observational
study.
ˍ
Nayak
L, Molinaro AM, Peters KB, Clarke JL, Jordan JT, de Groot JF,
Nghiemphu PL, Kaley TJ, Colman H, McCluskey C, Gaffey S, Smith T,
Cote DJ, Severgnini M, Yearley JH, Zhao Q, Blumenschein WM, Duda
DG, Muzikansky A, Jain RK, Wen PY, Reardon DA.
Randomized
phase II and biomarker study of pembrolizumab plus bevacizumab
versus pembrolizumab alone for recurrent glioblastoma
patients.
Clin
Cancer Res.
2020 Nov 16, 2021;27(4):1048-1057∟.
doi: 10.1158/1078-0432.CCR-20-2500∟.
PMID:
33199490∟.
Interventional study. ˍ
Sui
L, Li Y, Xu Z, Shen X.
Therapeutic
effect of thalidomide combined with temozolomide and
three-dimensional conformal radiotherapy for patients with
high-grade gliomas after operation.
J
BUON. 2020 Nov 16, 2020 Nov-Dec;25(6):2608-2615∟.
PMID: 33455103∟.
Observational study. ˍ
Topkan
E, Kucuk A, Ozdemir Y, Mertsoylu H, Besen AA, Sezen D, Bolukbasi
Y, Pehlivan B, Selek U.
Systemic
Inflammation Response Index Predicts Survival Outcomes in
Glioblastoma Multiforme Patients Treated with Standard Stupp
Protocol.
J
Immunol Res. 2020 Nov 16, 2020;2020:8628540∟.
doi: 10.1155/2020/8628540∟.
PMID: 33274245∟.
Observational study. ˍ
*
Wu
B, Wang W, Wang H, Zou Q, Hu B, Ye L, Hu Y, Xie Y, Huang N, Lan Q,
Cheng H, Dong J, Dai X.
Single-Cell
Sequencing of Glioblastoma Reveals Central Nervous System
Susceptibility to SARS-CoV-2.
Front
Oncol. 2020 Nov 16;10:566599∟.
doi: 10.3389/fonc.2020.566599∟.
PMID: 33312949∟.
Laboratory
investigation. ˍ
Bumes
E, Wirtz FP, Fellner C, Grosse J, Hellwig D, Oefner PJ, Häckl
M,
Linker R, Proescholdt M, Schmidt NO, Riemenschneider MJ, Samol C,
Rosengarth K, Wendl C, Hau P, Gronwald W, Hutterer M.
Non-Invasive
Prediction of IDH
Mutation
in Patients with Glioma WHO II/III/IV Based on F-18-FET PET-Guided
In Vivo 1H-Magnetic
Resonance Spectroscopy and Machine Learning.
Cancers
(Basel).
2020 Nov 17, 2020;12(11):3406∟.
doi: 10.3390/cancers12113406∟.
PMID:
33212941∟.
Observational
study.
ˍ
Gao
Y, Xiao X, Han B, Li G, Ning X, Wang D, Cai W, Kikinis R,
Berkovsky S, Di Ieva A, Zhang L, Ji N, Liu S.
Deep
Learning Methodology for Differentiating Glioma Recurrence From
Radiation Necrosis Using Multimodal Magnetic Resonance Imaging:
Algorithm Development and Validation.
JMIR
Med Inform.
2020 Nov 17, 2020;8(11):e19805∟.
doi: 10.2196/19805∟.
PMID:
33200991∟.
Observational
study.
ˍ
Gerstner
ER, Emblem KE, Yen YF, Dietrich J, Jordan JT, Catana C, Wenchin
KL, Hooker JM, Duda DG, Rosen BR, Kalpathy-Cramer J, Jain RK,
Batchelor TT.
Vascular
dysfunction promotes regional hypoxia after bevacizumab therapy in
recurrent glioblastoma patients.
Neurooncol
Adv. 2020 Nov 17, 2020;2(1):vdaa157∟.
doi: 10.1093/noajnl/vdaa157∟.
PMID: 33392506∟.
Observational
study.
ˍ
Ahmadipour
Y, Rauschenbach L, Santos A, Darkwah Oppong M, Lazaridis L,
Quesada CM, Junker A, Pierscianek D, Dammann P, Wrede KH,
Scheffler B, Glas M, Stuschke M, Sure U, Jabbarli R.
Preoperative
and early postoperative seizures in patients with glioblastoma-two
sides of the same coin?
Neurooncol
Adv. 2020 Nov 18, 2021;3(1):vdaa158∟.
doi: 10.1093/noajnl/vdaa158∟.
PMID: 33506201∟.
Observational study. ˍ
Labuschagne
JJ.
The
Use of 5-Aminolevulinic Acid to Assist Gross Total Resection of
Paediatric Posterior Fossa Tumours.
Pediatr
Neurosurg.
2020 Nov 18, 2020;55(5):268-279∟.
doi: 10.1159/000511289∟.
PMID:
33207361∟.
Observational study. ˍ
Gestrich
CK, Jajosky AN, Elliott R, Stearns D, Sadri N, Cohen ML, Couce
ME.
Molecular
Profiling of Pediatric and Adult Glioblastoma.
Am
J Clin Pathol.
2020 Nov 19, 2021;155(4):606-614∟.
doi: 10.1093/ajcp/aqaa172∟.
PMID:
33210143∟.
Laboratory investigation. ˍ
van
Kessel E, Huenges Wajer IMC, Ruis C, Seute T, Fonville S, De Vos
FYFL, Verhoeff JJC, Robe PA, van Zandvoort MJE, Snijders TJ.
Cognitive
impairments are independently associated with shorter survival in
diffuse glioma patients.
J
Neurol.
2020 Nov 19, 2021;268(4):1434-1442∟.
doi: 10.1007/s00415-020-10303-w∟.
PMID:
33211158∟.
Observational study. ˍ
Eisenhut
F, Schmidt MA, Putz F, Lettmaier S, Fröhlich
K, Arinrad S, Coras R, Luecking H, Lang S, Fietkau R, Doerfler A.
Classification
of Primary Cerebral Lymphoma and Glioblastoma Featuring Dynamic
Susceptibility Contrast and Apparent Diffusion Coefficient.
Brain
Sci.
2020 Nov 20, 2020;10(11):886∟.
doi: 10.3390/brainsci10110886∟.
PMID:
33233698∟.
Observational study. ˍ
Suwala
AK, Stichel D, Schrimpf D, Kloor M, Wefers AK, Reinhardt A, Maas
SLN, Kratz CP, Schweizer L, Hasselblatt M, Snuderl M,
Abedalthagafi MSJ, Abdullaev Z, Monoranu CM, Bergmann M, Pekrun A,
Freyschlag C, Aronica E, Kramm CM, Hinz F, Sievers P, Korshunov A,
Kool M, Pfister SM, Sturm D, Jones DTW, Wick W, Unterberg A,
Hartmann C, Dodgshun A, Tabori U, Wesseling P, Sahm F, von
Deimling A, Reuss DE.
Primary
mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a
distinct type with a poor prognosis.
Acta
Neuropathol.
2020 Nov 20, 2021;141(1):85-100∟.
doi: 10.1007/s00401-020-02243-6∟.
PMID:
33216206∟.
Laboratory investigation. ˍ
Feng
Y, Li G, Shi Z, Yan X, Wang Z, Jiang H, Chen Y, Li R, Zhai Y,
Chang Y, Zhang W, Yuan F.
A
novel methylation signature predicts radiotherapy sensitivity in
glioma.
Sci
Rep.
2020 Nov 23, 2020;10(1):20406∟.
doi: 10.1038/s41598-020-77259-9∟.
PMID:
33230136∟.
Observational study. ˍ
Hidaka
K, Fukushima H, Hosaka S, Muroi A, Yamamoto T, Mizumoto M, Sakurai
H, Takada H.
Cognitive
Functions of Pediatric Brain Tumor Survivors Treated With Proton
Beam Therapy: A Case Series.
J
Pediatr Hematol Oncol.
2020 Nov 23, 2021;43(8):e1205-e1209∟.
doi: 10.1097/MPH.0000000000002011∟.
PMID:
33235149∟.
Case report˰
ˍ
Lee
J, Wang N, Turk S, Mohammed S, Lobo R, Kim J, Liao E,
Camelo-Piragua S, Kim M, Junck L, Bapuraj J, Srinivasan A, Rao
A.
Discriminating
pseudoprogression and true progression in diffuse infiltrating
glioma using multi-parametric MRI data through deep learning.
Sci
Rep.
2020 Nov 23, 2020;10(1):20331∟.
doi: 10.1038/s41598-020-77389-0∟.
PMID:
33230285∟.
Observational study. ˍ
Lin
Z, Xu H, Yang R, Li Z, Zheng H, Zhang Z, Peng J, Zhang X, Qi S,
Liu Y, Huang G.
Effective
treatment of a BRAF V600E-mutant epithelioid glioblastoma patient
by vemurafenib: a case report.
Anticancer
Drugs. 2021 Jul 4, 2022;33(1):100-104∟.
doi: 10.1097/CAD.0000000000001130∟.
PMID: 34232949∟.
Case report˰
ˍ
Res
Square. 2020 Nov 23 [posted preprint]ˍ.
ˍ
Liu
KX, Ioakeim-Ioannidou M, Susko MS, Rao AD, Yeap BY, Snijders AM,
Ladra MM, Vogel J, Zaslowe-Dude C, Marcus KJ, Yock TI, Grassberger
C, Braunstein SE, Haas-Kogan DA, Terezakis SA, MacDonald SM.
A
Multi-institutional Comparative Analysis of Proton and Photon
Therapy-Induced Hematologic Toxicity in Patients With
Medulloblastoma.
Int
J Radiat Oncol Biol Phys. 2020 Nov 23, 2021;109(3):726-735∟.
doi: 10.1016/j.ijrobp.2020.09.049∟.
PMID: 33243479∟.
Observational study˰
ˍ
Mao
J, Zeng W, Zhang Q, Yang Z, Yan X, Zhang H, Wang M, Yang G, Zhou
M, Shen J.
Differentiation
between high-grade gliomas and solitary brain metastases: a
comparison of five diffusion-weighted MRI models.
BMC
Med Imaging.
2020 Nov 23, 2020;20(1):124∟.
doi: 10.1186/s12880-020-00524-w∟.
PMID:
33228564∟.
Observational
study.
ˍ
Roux
C, Revon-Rivière G, Gentet JC, Verschuur A, Scavarda D,
Saultier P, Appay R, Padovani L, André N.
Metronomic
Maintenance With Weekly Vinblastine After Induction With
Bevacizumab-Irinotecan in Children With Low-grade Glioma Prevents
Early Relapse.
J
Pediatr Hematol Oncol.
2020 Nov 23, 2021;43(5):e630-e634∟.
doi: 10.1097/MPH.0000000000002002∟.
PMID:
33235152∟.
Observational study˰ ˍ
Jaspers
JPM, Méndez Romero A, Wiggenraad R, Compter I, Eekers DBP,
Nout RMD, van den Bent M.
Pattern
of failure in IDH mutated, low grade glioma after radiotherapy -
Implications for margin reduction.
Radiother
Oncol.
2020 Nov 24, 2021;156:43-48∟.
doi: 10.1016/j.radonc.2020.11.019∟.
PMID:
33245948∟.
Observational study. ˍ
Hao
M, Hou S, Li W, Li K, Xue L, Hu Q, Zhu L, Chen Y, Sun H, Ju C,
Zhang C.
Combination
of metabolic intervention and T cell therapy enhances solid tumor
immunotherapy.
Sci
Transl Med.
2020 Nov 25, 2020;12(571):eaaz6667∟.
doi: 10.1126/scitranslmed.aaz6667∟.
PMID:
33239389∟.
Laboratory investigation. ˍ
*
Iorgulescu
JB, Gokhale PC, Speranza MC, Eschle BK, Poitras MJ, Wilkens MK,
Soroko KM, Chhoeu C, Knott A, Gao Y, Lim-Fat MJ, Baker GJ, Bonal
DM, Nguyen QD, Grant GRL, Ligon KL, Sorger PK, Chiocca EA,
Anderson AC, Kirschmeier PT, Sharpe AH, Freeman GJ, Reardon DA.
Concurrent
Dexamethasone Limits the Clinical Benefit of Immune Checkpoint
Blockade in Glioblastoma.
Clin
Cancer Res.
2020 Nov 25, 2021;27(1):276-287∟.
doi: 10.1158/1078-0432.CCR-20-2291∟.
PMID:
33239433∟.
Observational study. ˍ
Hanyu
T, Fujitani S, Ito A, Mizutani N.
Brain
metastasis from extramammary Paget's disease.
Nagoya
J Med Sci. 2020 Nov 26, 2020 Nov;82(4):791-798∟.
doi: 10.18999/nagjms.82.4.791∟.
PMID: 33311809∟.
Case report. ˍ
Steidl
E, Langen KJ, Hmeidan SA, Polomac N, Filss CP, Galldiks N, Lohmann
P, Keil F, Filipski K, Mottaghy FM, Shah NJ, Steinbach JP,
Hattingen E, Maurer GD.
Sequential
implementation of DSC-MR perfusion and dynamic [18F]FET
PET allows efficient differentiation of glioma progression from
treatment-related changes.
Eur
J Nucl Med Mol Imaging.
2020 Nov 26, 2021;48(6):1956-1965∟.
doi: 10.1007/s00259-020-05114-0∟.
PMID:
33241456∟.
Observational study. ˍ
Decuyper
M, Bonte S, Deblaere K, Van Holen R.
Automated
MRI based pipeline for segmentation and prediction of grade, IDH
mutation and 1p19q co-deletion in glioma.
Comput
Med Imaging Graph. 2020 Nov 27, 2021 Mar;88:101831∟.
doi: 10.1016/j.compmedimag.2020.101831∟.
PMID: 33482430∟.
Observational
study.
ˍ
Feng
Q, Li L, Li M, Wang X.
Immunological
classification of gliomas based on immunogenomic profiling.
J
Neuroinflammation.
2020 Nov 27, 2020;17(1):360∟.
doi: 10.1186/s12974-020-02030-w∟.
PMID:
33246490∟.
Laboratory investigation. ˍ
*
Niu
X, Yang Y, Zhou X, Zhang H, Zhang Y, Liu Y, Qing M.
A
prognostic nomogram for patients with newly diagnosed adult
thalamic glioma in a surgical cohort.
Neuro
Oncol.
2020 Nov 27, 2021;23(2):337-338∟.
doi: 10.1093/neuonc/noaa268∟.
PMID:
33244611∟.
Observational study. ˍ
Pinto
G, Saenz-de-Santa-Maria I, Chastagner P, Perthame E, Delmas C,
Toulas C, Moyal-Jonathan-Cohen E, Brou C, Zurzolo
C.
Patient-derived
glioblastoma stem cells transfer mitochondria through tunneling
nanotubes in tumor organoids.
Biochem
J. 2020 Nov 27, 2021;478(1):21-39∟.
doi: 10.1042/BCJ20200710∟.
PMID: 33245115∟.
Laboratory investigation. ˍ
Ayasoufi
K, Pfaller CK, Evgin L, Khadka RH, Tritz ZP, Goddery EN, Fain CE,
Yokanovich LT, Himes BT, Jin F, Zheng J, Schuelke MR, Hansen MJ,
Tung W, Parney IF, Pease LR, Vile RG, Johnson AJ.
Brain
cancer induces systemic immunosuppression through release of
non-steroid soluble mediators.
Brain.
2020
Nov 30, 2020;143(12):3629-3652∟.
doi: 10.1093/brain/awaa343∟.
PMID: 33253355∟.
Laboratory
investigation. ˍ
Goldman
DA, Reiner AS, Diamond EL, DeAngelis LM, Tabar V, Panageas
KS.
Lack
of survival advantage among re-resected elderly glioblastoma
patients: a SEER-Medicare study.
Neurooncol
Adv. 2020 Nov 29, 2021;3(1):vdaa159∟.
doi: 10.1093/noajnl/vdaa159∟.
PMID: 33506202∟.
Observational study. ˍ